Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States A Cost-Effectiveness Analysis

Publication: Annals of Internal Medicine
UBC Author(s): Kate Johnson (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
ISSN: 00034819
Volume: 177
Page Range: 155-164
Publication Date: February 2024